Earnings Feed
Start Free
Home/Filings/4/0000864268-07-000003
4//SEC Filing

BRADLEY PHARMACEUTICALS INC 4

Accession 0000864268-07-000003

CIK 0000864268operating
View on SEC.govCompany Profile

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 2:05 PM ET

Size

11.1 KB

Accession

0000864268-07-000003

Insider Transaction Report

Form 4
Period: 2007-03-21
BRADLEY PHARMACEUTICALS INCNYSE: BDY
GLASSMAN BRADLEY
Senior VP - Sales & Marketing
Transactions
  • Exercise/Conversion

    Common Stock

    2007-03-21$7.05/sh+30,000$211,500→ 74,494 total
  • Exercise/Conversion

    Stock Options (Right to buy)

    2007-03-21$7.05/sh−30,000$211,500→ 30,000 total
    Exercise: $7.05From: 2002-07-09Exp: 2011-07-08→ Common Stock (30,000 underlying)
Holdings

  • Common Stock

    (indirect: By 401(k))
    16,349

  • Common Stock

    (indirect: By 401(k))
    3,359

  • Common Stock

    (indirect: By Trust)
    15,620

  • Class B Common Stock

    (indirect: By Trust)
    20,880

  • Stock Options (Right to buy)

    Exercise: $13.41From: 2006-11-22Exp: 2015-11-21→ Common Stock (100,000 underlying)
    100,000

Documents

1 file

Issuer

BRADLEY PHARMACEUTICALS INC

CIK 0000864268

→
Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000864268

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 2:05 PM ET
Size
11.1 KB
View on SEC.gov